Exporting Medical Devices to Sweden: ÜTS, EUDAMED, CE and Label Language
Sweden is a Member State that requires every user to have access to information in Swedish and that runs its national registration system together with EUDAMED. This page brings together Läkemedelsverket's registration page, the Commission language table, MDCG 2022-16 and the ÜTS rules for a manufacturer established in Türkiye that will export medical devices to Sweden.
Auktoriserad representant: Not Needed for a Turkish Manufacturer
Läkemedelsverket's registration page says that a manufacturer established outside the EU/EEA registers in EUDAMED only if its authorised representative is in Sweden. A manufacturer established in Türkiye is not in this situation; because of the Customs Union it acts directly as a manufacturer in the Union market.
"'Union market' means the territory of the European Union Member States and is extended to Norway, Liechtenstein and Iceland because of the European Economic Area (EEA) and to Türkiye through the Customs Union Agreement."
Source: MDCG 2022-16 Guidance on Authorised Representatives, Turkish translation, footnote 1.
The definition points only to a manufacturer outside the Union.
"Authorised representative: a person established in the Union, who has received and accepted a written mandate from a manufacturer established outside the Union, to act on the manufacturer's behalf in relation to specified tasks with regard to the latter's obligations under this Regulation"
Source: MDCG 2022-16 Guidance on Authorised Representatives, Turkish translation, Definitions section.
The same provision in Turkish legislation:
"Where the manufacturer is not established in Türkiye or an EU member state, the device may be placed on the market only on the condition that the manufacturer appoints an authorised representative."
Source: Medical Device Regulation, Article 11, paragraph 1.
Swedish regional health authorities (regioner) ask for the manufacturer's SRN in tenders; the authorised representative field is left empty and a Customs Union explanation is added. Authorised representation is required for manufacturers outside Türkiye and the EU.
Label and Instructions for Use Language: Swedish
"Manufacturers shall ensure that the device is accompanied by the information set out in Section 23 of Annex I in an official Union language(s) determined by the Member State in which the device is made available to the user or patient. The particulars on the label shall be indelible, easily legible and clearly comprehensible to the intended user or patient."
Source: MDR (EU) 2017/745, Article 10(11).
Läkemedelsverket's language requirements page summarises it in two sentences: every user of a medical device in Sweden must be able to access information written in Swedish; information submitted to the authority is in Swedish or English. As its basis, the Commission language table points to Förordning (2021:631) med kompletterande bestämmelser till EU:s förordningar om medicintekniska produkter: label and instructions for use in Swedish for both patient and professional users (Chapter 3 Section 1); implant card in Swedish or English (Chapter 3 Section 1 second paragraph); declaration of conformity in Swedish or English (Chapter 3 Section 2); field safety notice in Swedish (Chapter 3 Section 1); conformity assessment certificates in Swedish or a language accepted by the notified body (Chapter 3 Section 2 second paragraph).
Result for a manufacturer in Türkiye: there is no English IFU option in Sweden on grounds of professional use; a Swedish label and IFU are prepared for every device, including hospital devices. If Swedish content is already being prepared for Finland, the same text can be used. For details of the Turkish rule that applies to supply in Türkiye, see the article on Turkish label and instructions for use.
Läkemedelsverket and National Registration
Sweden's competent authority is Läkemedelsverket (Swedish Medical Products Agency, Uppsala); it appears for the MDR and IVDR in the Commission's May 2026 national authority list. The agency's operator and device registration page (Registration of operators and devices, updated 24 June 2026) gives the rules in detail:
An operator established outside Sweden but within the EU/EEA does not register separately with Läkemedelsverket if it is properly registered in EUDAMED or in its own country.
Even if established outside Sweden, an operator that places devices on the market through the national medical information system (NMI) or that makes available in Sweden devices relabelled or repackaged under MDR Article 16(2)-(4) registers with Läkemedelsverket.
From 28 May 2026, EUDAMED actor registration is mandatory for manufacturers, authorised representatives, importers and system/procedure pack producers; other actors remain registered with Läkemedelsverket, not in EUDAMED.
In the role table on the page, distributors and distributors/importers that relabel/translate or repackage are among the roles subject to Läkemedelsverket registration.
Practical result for a manufacturer in Türkiye: registration is made in EUDAMED, and no separate registration with Läkemedelsverket is needed. If your Swedish distributor translates the label into Swedish and relabels, it registers with Läkemedelsverket itself for this activity under MDR Article 16. If you prepare the label yourself as the manufacturer, this additional registration disappears.
"Member States may maintain or introduce national provisions on registration of distributors of devices which have been made available on their territory."
Source: MDR, Article 30(2).
EUDAMED Registration and Sweden's Timing Note
Läkemedelsverket's page also explains the timing of registration: the device registration is made when the device is ready for sale and close to the start of sales, not during the development or clinical investigation stage; the actor registration may be needed before applying to a notified body.
"Before placing a device, other than a custom-made device, on the market, manufacturers, authorised representatives and importers shall, in order to register, submit to the electronic system referred to in Article 30 the information referred to in Section 1 of Part A of Annex VI, provided that they have not already registered in accordance with this Article."
Source: Medical Device Regulation (EU) 2017/745, Article 31(1).
"Before placing a device, other than a custom-made device, on the market, the manufacturer shall, in accordance with the rules of the issuing entity referred to in Article 27(2), assign a Basic UDI-DI as defined in Part C of Annex VI to the device and shall provide it to the UDI database together with the other core data elements referred to in Part B of Annex VI related to that device."
Source: MDR Article 29(1), Regulation (EU) 2017/745.
The amendment that sets the EUDAMED timetable:
"the obligations and requirements that relate to any of the electronic systems referred to in Article 33(2) shall apply from the date corresponding to 6 months from the date of publication of the notice referred to in Article 34(3), informing that the relevant electronic system is functional and meets the functional specifications drawn up pursuant to Article 34(1)."
Source: MDR Article 123(3)(d) introductory sentence [(EU) 2024/1860, Article 1(3)(a)].
As stated on the Commission's EUDAMED page, Decision (EU) 2025/2371 was published on 27 November 2025 and the four modules became mandatory as of 28 May 2026. The steps are in the articles on EUDAMED actor registration, EUDAMED device registration and legacy device registration; the support scope is EUDAMED registration consultancy.
The ÜTS Side of a Sweden Shipment: Export Notification and Free Sale Certificate
Shipments to Sweden are usually made by sea or combined transport; what matters for the ÜTS notification is the export declaration in Türkiye.
"An 'Export Notification' is made for individual products exported by the company."
Source: Guide on Individual Movement Notifications of the Medical Device Tracking System (TİTCK), Article 17, paragraph 1.
"When making an Export Notification in ÜTS, after querying by product number, lot and/or serial number, entering data in the Customs Declaration number and Quantity fields is mandatory."
Source: Guide on Individual Movement Notifications of the Medical Device Tracking System (TİTCK), Article 17, paragraph 2.
A wrong notification is corrected with an Export Cancellation Notification. The method is in the articles on ÜTS individual movement notifications and on exports, free zones and bonded warehouses in ÜTS; the service is on the individual notification procedures page.
A free sale certificate is not a condition for supply to Sweden; if requested, it is obtained from ÜTS under Article 60 of the Regulation.
"The Authority, for export purposes and at the request of a manufacturer or an authorised representative, shall issue a free sale certificate declaring that the manufacturer's or, as applicable, the authorised representative's place of business is registered domestically and that the device in question, bearing the CE marking under this Regulation, may be marketed in Türkiye and EU member states."
Source: Medical Device Regulation (Official Gazette 31499, 2.6.2021), Article 60, paragraph 1.
The application is in the free sale certificate (FSC) and ÜTS article. Nordic markets: Denmark and Finland.
Sweden summary table
TopicStatusCompetent authorityLäkemedelsverket (Swedish Medical Products Agency), UppsalaLabel / IFU languagePatient and professional user: Swedish (Förordning 2021:631, Chapter 3 Section 1); declaration of conformity in Swedish or English (Chapter 3 Section 2)National additional registration / notificationNone for a manufacturer in Türkiye; registration is in EUDAMED. A Swedish distributor that relabels/repackages registers with Läkemedelsverket (MDR Article 16/2-4)Is an AR requiredNo (manufacturer established in Türkiye, Customs Union; MDCG 2022-16 footnote 1)
Medical Device ÜTS Registration Consultancy for exports to Sweden
We handle the ÜTS product registration, export notifications and EUDAMED actor and device registration of manufacturers exporting to Sweden; we check that the Swedish label and IFU are consistent with the registration data. Get a price quote or call +90 505 580 46 22; for correspondence, info@medexmedikal.com.
Frequently Asked Questions
Is an English IFU enough for a hospital device in Sweden?
No. The Läkemedelsverket language page requires every user in Sweden to have access to information in Swedish; the Commission table lists the label and instructions for use as Swedish for both patient and professional users (Förordning 2021:631, Chapter 3 Section 1).
Do I have to register separately with Läkemedelsverket?
No. According to the Läkemedelsverket page, manufacturers register in EUDAMED from 28 May 2026; the Swedish registration is for NMI manufacturers, custom-made device manufacturers and distributors/importers that relabel or repackage under MDR Article 16(2)-(4).
What happens if the Swedish distributor translates the label itself?
According to the Läkemedelsverket page, a distributor that relabels or translates under MDR Article 16(2)-(4) registers with Läkemedelsverket. If you prepare the Swedish label as the manufacturer, this additional registration is not needed.
When should I register the device in EUDAMED?
The Läkemedelsverket page says the device registration should be made when the device is ready for sale and close to the start of sales, not during development or the clinical investigation stage. MDR Article 29(1) requires registration before placing on the market.
Which data are mandatory for an export notification in ÜTS?
Article 17(2) of the Individual Movement Notifications Guide: after querying by product number and lot/serial, the customs declaration number and quantity are mandatory. A free sale certificate is obtained from ÜTS only if the buyer requests it.
